Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-2

Pralmorelin, Growth Hormone Releasing Peptide-2, KP-102

Quick Stats
Studies 230
Trials 1
Score 2
1996 pubmed

Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats.

Okada. K K; Ishii. S S; Minami. S S; Sugihara. H H; Shibasaki. T T; Wakabayashi. I I

Key Findings

  • ICV (brain) injection of KP‑102 or human GHRH each increase food intake in free‑feeding rats.
  • Systemic (outside the brain) injection does not produce the same appetite‑stimulating effect.
  • Co‑administration of KP‑102 and GHRH in the brain produces a greater increase in food intake than either peptide alone.

Practical Outcomes

  • For biohackers, the study suggests that GHRP‑2 can stimulate appetite, but only when it reaches the central nervous system, which is not achievable with typical subcutaneous or oral dosing. Therefore, the finding has limited direct use for everyday protocols, though it highlights a potential central mechanism that could inform future research on appetite control.

Summary

In rats, injecting the growth‑hormone‑releasing peptide KP‑102 (a GHRP‑2 analogue) directly into the brain makes them eat more, and it works together with the natural hormone GHRH to boost food intake even further. This effect only happens when the peptide is delivered straight into the brain, not when given by normal injection.

Abstract

Recent evidence suggests that growth hormone-releasing peptides (GHRPs) mimic an unidentified native GH-releasing hormone (GHRH)-amplifying hormone. GHRH has been shown to stimulate food intake acting on the central nervous system. The present studies were conducted to test the hypothesis that GHRPs may also potentiate the central effect of GHRH on feeding in free-feeding rats. Intracerebroventricular (ICV) administration of picomole doses of a newly developed GHRP, KP-102, or human GHRH stimulated feeding, but the phenomenon was not reproduced by systemic injection. A prior ICV injection of a GHRH antagonist completely prevented the increase of food intake evoked by GHRH, but this pretreatment did not influence the increase in food intake induced by KP-102. When maximally effective doses of GHRH and KP-102 were co-administered ICV, the amount of food intake increased significantly compared with after ICV injection of a maximum dose of either peptide alone. These findings suggest that GHRPs stimulate food intake via a specific receptor for GHRPs in the central nervous system and amplify the central effect of GHRH on feeding.

Study Information

Provider

pubmed

Year

1996

DOI

10.1210/endo.137.11.8895390